Mdt

MiniMed's Grand Debut: Medtronic's Diabetes Arm Goes Public

Medtronic's Q3 Earnings: A Reality Check Prompts Analysts to Trim Forecasts

Beyond the Headlines: What's Moving Medtronic, Tesla, Starbucks, and Exxon Mobil?

A New Dawn for Diabetes Care: Medtronic's MiniMed Go App Receives FDA Nod

Edwards Lifesciences: A Heart of Gold, But What About the Price Tag?

A New Chapter for Diabetes Care: Medtronic's MiniMed Unit Files for US IPO

The Allure of Passive Income: A Glimpse into Sustained Dividend Streams

Following the Smart Money: Decoding This Week's Insider Trading Signals

Earnings Season's Tricky Dance: Why Market Euphoria Feels So Fragile

The Silent Scourge: Maharashtra's Resolute Stand Against Leprosy

The Unyielding Pillars: Why Dividend Aristocrats Endure (And Thrive Towards 2025)

Medtronic's Protracted Stagnation: Unraveling 1,100 Days of Flat Performance and What Lies Ahead

Unlocking Value: Why Analysts See Further Divestitures on Medtronic's Horizon

Wall Street Roars: Tech Titans, Crypto Currents, and Pharma Shakes Up Tuesday's Trading!

Medtronic Soars: Upgraded Outlook & Bold Board Moves Signal New Era Post-Elliott

Carlsmed's Personalized Spine Implants Revolutionize Care with Landmark Reimbursement Approval